Free Trial
NASDAQ:SNOA

Sonoma Pharmaceuticals (SNOA) Stock Price, News & Analysis

Sonoma Pharmaceuticals logo
$2.98 +0.06 (+2.05%)
Closing price 07/3/2025 01:04 PM Eastern
Extended Trading
$2.98 0.00 (0.00%)
As of 07/3/2025 04:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Sonoma Pharmaceuticals Stock (NASDAQ:SNOA)

Key Stats

Today's Range
$2.89
$3.07
50-Day Range
$2.85
$4.23
52-Week Range
$1.75
$9.37
Volume
23,564 shs
Average Volume
804,024 shs
Market Capitalization
$4.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SNOA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SNOA Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Sonoma Pharmaceuticals expands into UK market
See More Headlines

SNOA Stock Analysis - Frequently Asked Questions

Sonoma Pharmaceuticals' stock was trading at $2.69 on January 1st, 2025. Since then, SNOA stock has increased by 10.8% and is now trading at $2.98.

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) posted its quarterly earnings results on Tuesday, June, 17th. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.73) by $0.58. The firm earned $3.75 million during the quarter, compared to the consensus estimate of $4.44 million. Sonoma Pharmaceuticals had a negative net margin of 24.23% and a negative trailing twelve-month return on equity of 58.73%.

Shares of SNOA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sonoma Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Meta Platforms (META), NVIDIA (NVDA), Bristol Myers Squibb (BMY), Advanced Micro Devices (AMD), Ford Motor (F) and PayPal (PYPL).

Company Calendar

Last Earnings
6/17/2025
Today
7/04/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SNOA
Employees
180
Year Founded
1999

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$3.46 million
Pretax Margin
-20.35%

Debt

Sales & Book Value

Annual Sales
$14.29 million
Price / Cash Flow
N/A
Book Value
$2.73 per share
Price / Book
1.09

Miscellaneous

Free Float
1,579,000
Market Cap
$4.89 million
Optionable
Not Optionable
Beta
1.33

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:SNOA) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners